ciprofloxacin has been researched along with glutamic acid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Deguchi, T; Fukuda, H; Ishihara, S; Kawada, Y; Yasuda, M; Yokoi, S | 1 |
| Hooper, DC; Robicsek, A; Strahilevitz, J | 1 |
| Nagaraja, V; Sengupta, S | 1 |
| Ghosh, S; Nagaraja, V; Sengupta, S | 1 |
| Abdel-Zaher, AO; Afify, AH; El-Awaad, EA; El-Osely, GM; Farghaly, HM; Kamel, SM | 1 |
| Lubitz, D; Wendisch, VF | 1 |
| Gibson, H; Hussain, M; Mohammed, AR; Perrie, Y; Rahman, A; Warraich, AA | 1 |
8 other study(ies) available for ciprofloxacin and glutamic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
Topics: Anti-Infective Agents; Aspartic Acid; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Genes, Bacterial; Glutamic Acid; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Selection, Genetic; Serine | 2000 |
Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Glutamic Acid; Microbial Sensitivity Tests; Molecular Sequence Data; Protein Structure, Tertiary; Staphylococcus aureus; Topoisomerase II Inhibitors | 2006 |
Inhibition of DNA gyrase activity by Mycobacterium smegmatis MurI.
Topics: Amino Acid Isomerases; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cloning, Molecular; Drug Resistance, Bacterial; Gene Dosage; Glutamic Acid; Mycobacterium smegmatis; Recombinant Proteins; Topoisomerase II Inhibitors | 2008 |
Moonlighting function of glutamate racemase from Mycobacterium tuberculosis: racemization and DNA gyrase inhibition are two independent activities of the enzyme.
Topics: Amino Acid Isomerases; Anti-Bacterial Agents; Bacterial Proteins; Cell Wall; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Glutamic Acid; Mutagenesis, Site-Directed; Mycobacterium smegmatis; Mycobacterium tuberculosis; Peptidoglycan; Topoisomerase II Inhibitors | 2008 |
Involvement of glutamate, oxidative stress and inducible nitric oxide synthase in the convulsant activity of ciprofloxacin in mice.
Topics: Animals; Anti-Infective Agents; Brain; Ciprofloxacin; Dose-Response Relationship, Drug; Glutamic Acid; Glutathione; Injections, Intraperitoneal; Male; Malondialdehyde; Mice; Nitric Oxide Synthase Type II; Oxidative Stress; RNA, Messenger; Seizures | 2012 |
Ciprofloxacin triggered glutamate production by Corynebacterium glutamicum.
Topics: Amino Acids; Bacterial Proteins; Biotin; Ciprofloxacin; Corynebacterium glutamicum; DNA Gyrase; Glutamic Acid; Industrial Microbiology; Ketoglutarate Dehydrogenase Complex; Ketoglutaric Acids; Metabolic Networks and Pathways; Nitrogen; RNA; Topoisomerase II Inhibitors; Transcription, Genetic | 2016 |
Evaluation of anti-biofilm activity of acidic amino acids and synergy with ciprofloxacin on Staphylococcus aureus biofilms.
Topics: Anti-Bacterial Agents; Aspartic Acid; Bacterial Adhesion; Biofilms; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Synergism; Glutamic Acid; Microbial Sensitivity Tests; Staphylococcus aureus | 2020 |